Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
Status:
Withdrawn
Trial end date:
2021-02-19
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the effect of multiple doses of rifampin on
the pharmacokinetics of vonoprazan in healthy participants.